MS Research Update — September 16, 2026
Updated Thesis
Morgan Stanley is a diversified capital-markets and wealth-management franchise spanning institutional securities, advisor-led and self-directed wealth, workplace services, and investment management. Business quality is solid but inherently cyclical: it combines $8.084 trillion of wealth client assets and $2.004 trillion of investment-management AUM/AUS with a strengthening 15.5% institutional peer wallet share, yet trading and deal activity remain important earnings drivers. Fundamentals were exceptionally strong in the most recent quarter, with revenue growth of 22.4% and earnings growth of 57.7%, while TTM operating and net margins were 20.7% and 16.0%, respectively, and ROE was 18.1%.
The investment grade as of this refresh is C — average business quality. Medium-tier business, expensive-tier valuation with 15.9% upside to $239 fair value.
Grade Change
In this research cycle, the investment grade for Morgan Stanley moved from B to C. Medium-tier business, expensive-tier valuation with 15.9% upside to $239 fair value.
Key Metrics at a Glance
- Revenue growth: +22.4% year over year
- Net margin: 16.0%
- Fair value upside: +15.9% to our estimate of $239
Current price: $206.27
These figures reflect our most recent data pull and are one input into a multi-factor valuation framework.
Our 12–18 Month Outlook
Quality companies held over a multi-year horizon benefit from compounding fundamentals and the patience to ride through short-term volatility. Morgan Stanley remains in our covered universe with a average-quality assessment. We update research when material data changes — earnings revisions, management shifts, or regime changes in valuation — not on every price fluctuation.
Long-term accumulation of quality businesses at fair or better prices is the core of the Patient Accumulator approach. Research updates like this one inform whether to add, hold, or wait for a better zone — not whether to react to short-term price moves.
[View full MS research →](/stocks/MS)